Authors:
TASSANEEYAKUL W
BIRKETT DJ
MCMANUS ME
TASSANEEYAKUL W
VERONESE ME
ANDERSSON T
TUKEY RH
MINERS JO
Citation: W. Tassaneeyakul et al., CAFFEINE METABOLISM BY HUMAN HEPATIC CYTOCHROMES P450 - CONTRIBUTIONSOF 1A2, 2E1 AND 3A ISOFORMS, Biochemical pharmacology, 47(10), 1994, pp. 1767-1776
Authors:
MANT A
WHICKER SD
MCMANUS P
BIRKETT DJ
EDMONDS D
DUMBRELL D
Citation: A. Mant et al., BENZODIAZEPINE UTILIZATION IN AUSTRALIA - REPORT FROM A NEW PHARMACOEPIDEMIOLOGIC DATABASE, Australian journal of public health, 17(4), 1993, pp. 345-349
Authors:
VERONESE ME
MINERS JO
REES DLP
BIRKETT DJ
Citation: Me. Veronese et al., TOLBUTAMIDE HYDROXYLATION IN HUMANS - LACK OF BIMODALITY IN 106 HEALTHY-SUBJECTS, Pharmacogenetics, 3(2), 1993, pp. 86-93
Authors:
ANDERSSON T
LAGERSTROM PO
MINERS JO
VERONESE ME
WEIDOLF L
BIRKETT DJ
Citation: T. Andersson et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR HUMAN LIVER MICROSOMAL OMEPRAZOLE METABOLISM, Journal of chromatography. Biomedical applications, 619(2), 1993, pp. 291-297
Authors:
ANDERSSON T
MINERS JO
VERONESE ME
TASSANEEYAKUL W
TASSANEEYAKUL W
MEYER UA
BIRKETT DJ
Citation: T. Andersson et al., IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING OMEPRAZOLE METABOLISM, British journal of clinical pharmacology, 36(6), 1993, pp. 521-530
Authors:
TASSANEEYAKUL W
BIRKETT DJ
VERONESE ME
MCMANUS ME
TUKEY RH
QUATTROCHI LC
GELBOIN HV
MINERS JO
Citation: W. Tassaneeyakul et al., SPECIFICITY OF SUBSTRATE AND INHIBITOR PROBES FOR HUMAN CYTOCHROMES-P450 1A1 AND 1A2, The Journal of pharmacology and experimental therapeutics, 265(1), 1993, pp. 401-407
Authors:
TASSANEEYAKUL W
VERONESE ME
BIRKETT DJ
GONZALEZ FJ
MINERS JO
Citation: W. Tassaneeyakul et al., VALIDATION OF 4-NITROPHENOL AS AN IN-VITRO SUBSTRATE PROBE FOR HUMAN LIVER CYP2E1 USING CDNA EXPRESSION AND MICROSOMAL KINETIC TECHNIQUES, Biochemical pharmacology, 46(11), 1993, pp. 1975-1981